title: Heparin-induced thrombocytopenia, anomalous laboratory findings lead to the correct diagnosis.
authors.forename: Yuji
authors.initials: Y
authors.lastname: Nomoto
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Hirose
authors.forename: Toshiharu
authors.initials: T
authors.lastname: Tanaka
authors.forename: Hidenori
authors.initials: H
authors.lastname: Kinoshita
authors.forename: Yosihiko
authors.initials: Y
authors.lastname: Yamazaki
mesh_terms: D002544:Cerebral Infarction / Q000209:etiology / Q000628:therapy; D019411:Clinical Laboratory Techniques; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D016670:Gabexate / Q000008:administration & dosage; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D010976:Platelet Count; D017713:Platelet Transfusion; D012680:Sensitivity and Specificity; D013921:Thrombocytopenia / Q000139:chemically induced / Q000175:diagnosis* / Q000628:therapy; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D016670:Gabexate; D006493:Heparin